MCAZ PVCT GL02 Rev 2 May 2024 PHARMACOVIGILANCE GUIDELINE FOR PHARMACEUTICAL INDUSTRY

5 days ago

Substandard and falsified (SF) medicines threaten millions of people worldwide.Report to the MCAZ, any suspected SF products you may encounter. The Authority urges the public to access registered medicines from licenced persons and premises. #medsafety ... See MoreSee Less

Photo

View on Facebook

Medicines Control Authority of Zimbabwe

6 days ago

Today, the Authority joins the global community in commemorating #WorldAIDSDay Day 2025.MCAZ reaffirm its commitment to protecting public health by ensuring access to safe, effective, and good-quality medicines and medical devices.Last month, the Authority approved and registered #lenacapavir, an innovative long-acting medicine for pre-exposure prophylaxis (PrEP) to help prevent HIV-1 infection—supporting national and global efforts in the fight against HIV and AIDS.Together, we can strengthen the response, save lives, and build a healthier future.#WorldAIDSDay ... See MoreSee Less

Photo

View on Facebook

Medicines Control Authority of Zimbabwe is with Zambia Medicines Regulatory Authority - ZAMRA and 6 others.

2 weeks ago

🚨 ANNOUNCEMENT 🔊 The Medicines Control Authority of Zimbabwe (MCAZ) announces the expedited approval of #Lenacapavir, an innovative long-acting medicine for pre-exposure prophylaxis (PrEP) to prevent HIV-1 infection. The application, submitted by Gilead on the 29th of October 2025, underwent a rigorous evaluation and was finalised in twenty-three (23) days, demonstrating the Authority’s commitment to ensuring timely access to essential, life-saving health products.The registration of #Lenacapavir marks a significant advancement in Zimbabwe’s HIV prevention strategy. By providing a long-acting alternative to daily oral #PrEP, this product has the potential to improve adherence and expand prevention options for populations most vulnerable to HIV infection.🔴 Details: portal.mcaz.co.zw/wp-content/uploads/2025/11/MEDIA-RELEASE-MCAZ-Registers-LENACAPAVIR_RvdDK-1ZAM.pdf ... See MoreSee Less

Call Now

Photo

View on Facebook

Medicines Control Authority of Zimbabwe

2 weeks ago

MCAZ at the Zimbabwe Antimicrobial Resistance (AMR) Conference 202519–20 November | HICCQuality-assured medicines are essential in protecting public health and preventing the spread of antimicrobial resistance (AMR).At this year’s conference, MCAZ showcased its (handheld) portable field detection technologies that help rapidly identify substandard and falsified medicines in both human and veterinary sectors. These innovations strengthen surveillance beyond the laboratory and support timely regulatory action.The Authority also had the opportunity to demonstrate the devices to the Minister of Ministry of Health and Child Care, highlighting the importance of technology and innovation in the fight against antimicrobial resistance.Poor-quality medicines fuel AMR. Through strong surveillance and a One Health approach, MCAZ continues to protect people, animals, and the environment.#AntimicrobialResistanceAwareness ... See MoreSee Less

Photo

View on Facebook

MCAZ PVCT GL02 Rev 2 May 2024 PHARMACOVIGILANCE GUIDELINE FOR PHARMACEUTICAL INDUSTRY

QUICK LINKS

FACEBOOK FEED

X FEED

CONTACT US